Blackrock Health Sciences Stock Return On Equity
| BMEZ Stock | USD 14.13 0.02 0.14% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess BlackRock Health's long-term financial health and intrinsic value.
BlackRock | Build AI portfolio with BlackRock Stock |
BlackRock Health Sciences Company Return On Equity Analysis
BlackRock Health's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, BlackRock Health Sciences has a Return On Equity of 0.0. This indicator is about the same for the Health Care Providers & Services average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
BlackRock Fundamentals
| Shares Outstanding | 101.25 M | ||||
| Shares Owned By Institutions | 34.42 % | ||||
| Number Of Shares Shorted | 102.19 K | ||||
| Price To Book | 0.86 X | ||||
| Price To Sales | 58.03 X | ||||
| Short Ratio | 0.36 X | ||||
| Earnings Per Share | 0.21 X | ||||
| Market Capitalization | 1.43 B | ||||
| Total Asset | 3.09 B | ||||
| Retained Earnings | 1.52 B | ||||
| Annual Yield | 0.14 % | ||||
| Net Asset | 3.09 B |
About BlackRock Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BlackRock Health Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BlackRock Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BlackRock Health Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BlackRock Stock Analysis
When running BlackRock Health's price analysis, check to measure BlackRock Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BlackRock Health is operating at the current time. Most of BlackRock Health's value examination focuses on studying past and present price action to predict the probability of BlackRock Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BlackRock Health's price. Additionally, you may evaluate how the addition of BlackRock Health to your portfolios can decrease your overall portfolio volatility.